4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
3.320
+0.240 (7.79%)
At close: May 12, 2025, 4:00 PM
3.320
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $153.80 million as of May 12, 2025. Its market cap has decreased by -87.60% in one year.
Market Cap
153.80M
Enterprise Value
-280.79M
1-Year Change
-87.60%
Ranking
Category
Stock Price
$3.32
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $153.80M, a decrease of -73.50%. That is a compound annual growth rate of -26.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 142.68M | -44.59% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | 1.10B | 89.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |